{"VoteId":84224,"SessionId":71,"PresidentVote":null,"Bill":[{"BillId":26592,"BillNumberOnly":1099,"BillNumber":1099,"BillType":"HB","Title":"reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance."}],"RollCalls":[{"FirstName":"Tamara","FormattedUniqueName":"Grove","LastName":"Grove","Picture":null,"SessionMemberId":4756,"UniqueName":"Grove","Vote":0,"Vote1":"Yea","VoteVote":1},{"FirstName":"Carl","FormattedUniqueName":"Perry","LastName":"Perry","Picture":"perry_2019.jpg","SessionMemberId":4800,"UniqueName":"Perry","Vote":1,"Vote1":"Yea","VoteVote":1},{"FirstName":"Tim","FormattedUniqueName":"Reed","LastName":"Reed","Picture":"reed_2019.jpg","SessionMemberId":4807,"UniqueName":"Reed","Vote":2,"Vote1":"Excused","VoteVote":3},{"FirstName":"Jamie","FormattedUniqueName":"Smith","LastName":"Smith","Picture":null,"SessionMemberId":4821,"UniqueName":"Smith","Vote":3,"Vote1":"Yea","VoteVote":1},{"FirstName":"Curt","FormattedUniqueName":"Voight","LastName":"Voight","Picture":null,"SessionMemberId":4828,"UniqueName":"Voight","Vote":4,"Vote1":"Yea","VoteVote":1},{"FirstName":"Sydney","FormattedUniqueName":"Davis","LastName":"Davis","Picture":"davis, sydney rep-2525 full rt.jpg","SessionMemberId":4743,"UniqueName":"Davis","Vote":5,"Vote1":"Yea","VoteVote":1},{"FirstName":"Kevin","FormattedUniqueName":"Jensen (Kevin)","LastName":"Jensen","Picture":"jensen_kevin_2019.jpg","SessionMemberId":4769,"UniqueName":"Jensen (Kevin)","Vote":6,"Vote1":"Yea","VoteVote":1}],"Yeas":6,"Nays":0,"Excused":1,"Absent":0,"Present":0,"NotVoting":0,"actionLog":{"ActionCommitteeId":1282,"ActionDate":"2026-02-25T08:00:00-06:00","ActionLogId":479797,"ConferenceCommitteeId":null,"FullName":"Senate Health and Human Services","SessionId":71,"StatusText":"Do Pass"}}